1. Kaprin A.D., Starinskii V. V., Petrova G. V. (red.). Zlokachestvennye novoobrazovaniya v Rossii v 2014 godu (zabolevaemost' i smertnost'). M.: FGBU «MNIOI im. P. A. Gertsena» Minzdrava Rossii, 2016. 250 s.
2. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer, 2015, Mar 1, 136(5): E359-86.
3. de Gramont A, Bosset JF, Milan C, Rougier P, Bouche O, Etienne PL, Morvan F, Louvet C, Guillot T, Francois E, Bedenne L. Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study. J. Clin. Oncol., 1997, 15(2): 808-815.
4. Kohne C-H, Wils J, Lorenz M, Schoffski P, Voigtmann R, Bokemeyer C, Lutz M, Kleeberg U, Ridwelski K, Souchon R, El-Serafi M, Weiss U, Burkhard O, Ruckle H, Lichinitser M, Langenbuch T, Scheithauer W, Baron B, Couvreur ML, Schmoll HJ. Randomized Phase III Study of High-Dose Fluorouracil Given As a Weekly 24-Hour Infusion With or Without Leucovorin Versus Bolus Fluorouracil Plus Leucovorin in Advanced Colorectal Cancer: European Organization of Research and Treatment of Cancer Gastrointestinal Group Study 40952. J. Clin. Oncol., 2003, 21(20): 3721-3728.
5. Thirion P, Michielis S, Pignon JP, Buyse M, Braud AC, Carlson RW, O´Connell M, Sargent P, Piedbois P, Meta-analysis Group in Cancer. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: an update metaanalysis. J. Clin. Oncol., 2004, 22(18): 3766-3775.